Advancements in autonomous vehicle and robotics applications represent key medium-term catalysts for lidar technology adoption. Strategic positioning in the competitive lidar sector depends on sensor innovation, software integration, and partnerships with automotive and industrial players.

Fisker Inc. (FSR) was delisted from the NYSE in March 2024 and now trades on OTC Pink Sheets under the ticker FSRNQ at approximately $0.0007 per share. The company filed for Chapter 11 bankruptcy protection in June 2024 and has since transitioned to a court-approved liquidation plan, effectively ending its operations as a going concern.

Ascendis Pharma (ASND) shares climbed approximately 12.37% over the past 30 days, rising from $231.20 on June 16 to $259.80 on July 16, 2026. Inclusion in multiple Russell indexes — including the Russell 1000 and Russell MidCap — triggered a sharp single-day surge of roughly 10% on June 25, accompanied by the stock's highest trading volume in months.

Genuine Parts Company (GPC) shares surged approximately 18.4% over the last 30 days, driven primarily by O'Reilly Automotive's reported $10 billion cash bid for GPC's NAPA auto parts division. The stock jumped 12.9% in a single session on July 2, 2026, following the acquisition report, with volume more than triple the daily average.

Quantinuum (QNT) shares have pulled back roughly 9.9% over the last 30 days, trading near $56.52 after a post-IPO rally that pushed the stock as high as $86.79 in early July. The quantum computing company went public on June 5, 2026, at $60 per share in the largest IPO by a pure-play quantum firm, raising $1.68 billion.

Guardant Health (GH) shares surged approximately 21.7% over the last 30 days, climbing from $127.34 on June 16 to $155.00 by July 16, 2026. Inclusion in the Russell 1000 Index in late June triggered a wave of institutional buying and record trading volumes, with June 26 alone seeing over 18.7 million shares change hands.

Insmed shares gained approximately 9% over the 30-day period through mid-July 2026, reflecting growing commercial traction for newly launched Brinsupri in non-cystic fibrosis bronchiectasis (NCFB). The stock remains well below its 52-week high of $212.75, trading near $107, as the company works to scale its respiratory franchise and narrow operating losses.

Moderna shares have surged approximately 124% year to date through mid-July 2026, dramatically outperforming the broader biotech sector, while the 30-day net change remains a modest +2.2% following a sharp pullback from recent highs. The stock experienced a volatile short squeeze in late June, spiking from around $60 to an intra-quarter high above $85 before retracing to the low $60s as momentum cooled.

Affirm Holdings (AFRM) climbed approximately 12.9% over the last 30 days, rising from a closing price of $70.73 on June 17, 2026, to $79.84 on July 16, 2026. The stock has gained roughly 23.8% over the broader quarter, driven by a series of analyst upgrades, strong earnings results, and expanding merchant partnerships.

Natera (NTRA) surged approximately 19% over the last 30 days, climbing from $226.44 on June 17 to $269.83 as of July 16, 2026, outpacing broader market and healthcare sector benchmarks. A finalized Medicare local coverage determination (LCD) for the Prospera transplant portfolio significantly expanded reimbursement for kidney, heart, and lung surveillance testing, driving renewed investor enthusiasm.

Roblox (RBLX) shares climbed approximately 12.5% over the last 30 days, rising from $48.02 on June 17, 2026, to $54.01 at the close on July 16, 2026. The rally was fueled by stabilizing user metrics following the global rollout of Kids and Select accounts, easing investor concerns about age-verification headwinds.

Revolution Medicines (RVMD) surged approximately 14% over the last 30 days, climbing from $156.58 on June 16 to $179.18 by July 16, 2026, driven by sustained momentum from landmark Phase 3 pancreatic cancer data. The broader quarterly trend underscores a powerful rally of roughly 20%, with shares advancing from around $149 in mid-April as the company's daraxonrasib program continued to deliver clinical and regulatory catalysts.

Axon Enterprise (AXON) surged approximately 28% over the last 30 days, climbing from a June 17 close of $423.01 to $541.75 as of July 16, 2026. A Needham price target upgrade from $600 to $750 on July 6, driven by strong bookings checks and a major Los Angeles Police Department contract expansion, served as the primary catalyst for the rally.

Sea Limited shares surged approximately 16.9% over the past 30 days, climbing from $90.84 on June 17 to $106.22 on July 16, 2026. The rally was fueled by a bullish DBS analyst note projecting second-quarter results ahead of consensus, renewed optimism around Shopee's competitive positioning, and growing investor enthusiasm for Sea's AI integration narrative.

DoorDash (DASH) shares climbed approximately 12.5% over the past 30 days, rising from $165.66 on June 17 to $186.36 as of July 16, 2026. The rally was fueled by a combination of strategic partnership announcements, including integrations with Shopify and AutoParts.com, and favorable analyst actions such as price-target hikes from Jefferies and KeyCorp.

HOOD shares have remained effectively flat over the last 30 days, closing at $106.02 on July 16, 2026, versus $105.20 on June 17 — a modest gain of approximately 0.8%. Over the broader quarter, the stock has rallied roughly 17%, recovering sharply from its post-Q1-earnings trough near $71 in late April.

GE Vernova shares closed at $1,036.22 on July 16, 2026, reflecting a gain of approximately 5.5% over the trailing 30-day period, recovering from a volatile trading range that saw the stock dip below $870 in early June. The company's $163 billion backlog and 71% organic order growth in Q1 2026 underscore surging demand for gas turbines, grid equipment, and electrification solutions tied to AI data center buildouts.

State Street reported record revenue of $4.05 billion for the second quarter of 2026, up 23% year over year. Earnings per share reached $3.65, surpassing the consensus estimate of $3.30 by $0.35.

U.S. Bancorp reported diluted earnings per share of $1.35 for the second quarter of 2026, up 22% year-over-year and above consensus estimates. Net revenue reached a record $7.71 billion, reflecting 10% year-over-year growth driven by higher net interest and noninterest income.

Prologis reported Q2 2026 earnings per share of $1.63, exceeding the consensus estimate of $1.53. Revenue reached $2.43 billion, surpassing analyst expectations of $2.16 billion and rising 11.1% year-over-year.